Low-Dose Prempro Boosts Premarin Family
This article was originally published in The Pink Sheet Daily
Executive Summary
New prescriptions for low-dose Prempro increase 47% in second quarter, Wyeth Exec VP Poussot said. Low-dose Prempro represents 60% of Prempro prescriptions. Premarin prescriptions continue to decrease but the decline may be slowing down.
You may also be interested in...
Prempro Prescriptions On The Rise Thanks To DTC Campaign, Wyeth Says
Company sees a “small but consistent” increase in prescription volume and share for the hormone therapy, VP O’Connor says. Growth could indicate “swinging back of the pendulum” following two-year downturn resulting from the Women’s Health Initiative results.
Italy Leads European Push Into Conditional Reimbursement
Italy claims to have pushed farther into managed entry agreements than other European countries with strong clawback provisions on new drugs – particularly cancer drugs – if they don't work as well as their manufacturers claim. The financial clawbacks are supported by extensive outcome data collection across the country's twenty regions.
Changes To The NHS: How Can Pharma Best Position Itself?
The U.K.’s Health and Social Care Bill was introduced into Parliament on Jan. 19, offering a new commercial landscape best navigated by pharma through bolstered relationships with general practitioners.